臨床外科66巻6号

2011年06月発行

特集 栄養療法―最新の知見と新たな展開

〔栄養療法における製剤〕

EN製剤―ラインナップとそれぞれの特徴

著者： 田中芳明¹

所属機関： ¹久留米大学医学部外科学講座小児外科部門

ページ範囲：P.731 - P.741

文献概要

【ポイント】

◆最近，経腸栄養剤は各種病態に配慮した製品が充実してきているが，それぞれがいまだ完全なものとはいえず，時には数種類の栄養剤を組み合わせることもある．

◆経腸栄養剤の選択において重要なことは，栄養剤中の個々の栄養素の効果を理解し，各種病態に適した栄養素を含有するように選択，決定することである．

◆栄養剤の投与にあたっては，定期的に栄養評価を行い，適宜その選択を見直す必要がある．

参考文献

1）田中芳明，中溝博隆，秋吉建二郎，他：病態別栄養剤の使い分け（1）．臨床栄養 104：593-598，2004

2）田中芳明，中溝博隆，秋吉建二郎，他：病態別栄養剤の使い分け（3）．臨床栄養 105：77-80，2004

3）田中芳明：NST栄養管理パーフェクトガイド（下），医歯薬出版，2007，p47，pp107-123

4）日本静脈・経腸栄養研究会（編）：静脈・経腸栄養ガイドライン　へるす出版，1998

5）Okubo T, Ishihara N, Takahashi H, et al：Effects of partially hydrolyzed guar gum intake on human intestinal microflora and its metabolism. Biosci Biotechnol Biochem 58：1364-1369, 1994

6）Cummings JH：Short-chain fatty acid enemas in the treatment of distal ulcerative colitis. Eur J Gastroenterol Hepatol 9：149-153, 1997

7）Scheppach W, Muller JG, Boxberger F, et al：Histological changes in the colonic mucosa following irrigation with short-chain fatty acids. Eur J Gastroenterol Hepatol 9：163-168, 1997

8）Di Sabatino A, Morera R, Ciccocioppo R, et al：Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther 22：789-794, 2005

9）Segain JP, Raingeard de la Blétière D, Sauzeau V, et al：Butyrate inhibits inflammatory responses through NFκB inhibition：implications for Crohn's disease. Gut 47：397-403, 2000

10）LührsH, Gerke T, Müller JG, et al：Butyrate inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 37：458-466, 2002

11）田中芳明，溝手博義：臨床におけるImmunonutritionの展開．臨床栄養 102：573-580，2003

12）Parisi GC, Zilli M, Miani MP, et al：High-fiber diet supplementation in patients with irritable bowel syndrome（IBS）：a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum（PHGG）. Dig Dis Sci 47：1697-1704, 2002

13）Yamada K, Tokunaga Y, Ikeda A, et al：Dietary effect of guar gum and its partially hydrolyzed product on the lipid metabolism and immune function of Sprague-Dawley rats. Biosci Biotechnol Biochem 63：2163-2167, 1999

14）田中芳明，中溝博隆，秋吉建二郎，他：病態別栄養剤の使い分け（2）．臨床栄養 104：879-884，2004

15）Beale RJ, Bryg DJ, Bihari DJ：Immunonutrition in the critically ill：a systematic review of clinical outcome. Crit Care Med 27：2799-2805, 1999

16）Heyland DK, Novak F, Drover JW, et al：Should immunonutrition become routine in the critically ill patients?：a systematic review of the evidence. JAMA 286：944-953, 2001

17）Moore FA, Feliciano DV, Andrassy RJ, et al：Early enteral feeding, compared with parenteral, reduces postoperative septic complications：the results of a meta-analysis. Ann Surg 216：172-183, 1992

18）Kudsk KA, Croce MA, Fabian TC, et al：Enteral versus parenteral Feeding：effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 215：503-513, 1992

19）Goodyear-Bruch C, Pierce JD：Oxidative stress in critic ill patients. J Clin Care 11：543-551, 2002

20）Bukan MH, Bukan N, Kaymakcioglu N, et al：Effects of open vs. laparoscopic cholecystectomy on oxidative stress. Tohoku J Exp Med 202：51-56, 2004

21）Nathens AB, Neff MJ, Jurkovich GJ, et al：Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236：814-822, 2002

22）Berger MM, Baines M, Wardle CC, et al：Influence of early trace element and vitamin E supplements on antioxidant status after major trauma：a controlled trial. Nutr Res 21：41-54, 2001

23）Heyland DK, Dhaliwal R, Suchner U, et al：Antioxidant nutrients：a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31：327-337, 2005

24）Jones NE, Heyland DK：Pharmaconutrition：a new emerging paradigm. Curr Opin Gastroenterol 24：215-222, 2008

25）Suchner U, Heyland DK, Peter K：Immune-modulatory actions of arginine in the critically ill. Br J Nut 87：S121-132, 2002

26）Stechmiller JK, Childress B, Porter T：Arginine immunonutrition in critically ill patients：a clinical dilemma. Am J Crit Care 13：17-23, 2004

27）Britton RS, Bacon BR：Role of free radicals in liver diseases and hepatic fibrosis. Hepato-Gastroenterol 41：343-348, 1994

28）Lee KS, Buck M, Houglum K, et al：Activation of hepatic satellite cells by TGFα and collagen type Ⅰ is mediated by oxidative stress through c-myb expression. J Clin Invest 96：2461-2468, 1995

29）Cadenas E：Biochemistry of oxygen toxicity. Annu Rev Biochem 58：79-110, 1989

30）Weisinger R, Fridovich I：Mitochondrial superoxide dismutase：site of synthesis and intramitochondrial localization. J Biol Chem 248：4793-4796, 1973

31）Oka S, Ogino K, Matsuura S, et al：Human serum immuno-reactive copper, zinc-superoxide dismutase assayed with an enzyme monoclonal immunosorbent in patients with digestive cancer. Clin Chim Acta 182：209-219, 1989

32）Ren J, Chung SH：Anti-inflammatory effect of alpha-linolenic acid and its mode of action through the inhibition of nitric oxide production and inducible nitric oxide synthase gene expression via NFκB and mitogen-activated protein kinase pathways. J Agric Food Chem 55：5073-5080, 2007

33）Zhao Y, Joshi-Barve S, Barve S, et al：Eicosapentaenoic acid prevents LPS-induced TNFα expression by preventing NFκB activation. J Am Coll Nutr 23：71-78, 2004

34）Borghaei H, Borghaei RC, Ni X, et al：Evidence that suppression of IL-1 induced collagenase mRNA expression by dihomogamma-linolenic acid（DGLA）involves inhibition of NFκB binding. Inflamm Res 46（Suppl 2）：S177-178, 1997

35）Zhi Zhong, Froh M, Lehnert M, et al：Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats. Am J Physiol Gastrointest Liver Physiol 285：G1004-1013, 2003

36）Ebadi M, Sharma SK, Wanpen S, et al：Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factor-kappa B activation. J Cell Mol Med 2：213-222, 2004

37）Jain SK, Kannan K：Chromium chloride inhibits oxidative stress and TNFα secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem Biophys Res Commun 289：687-691, 2001

38）von Bulow V, Dubben S, Engelhardt G, et al：Zinc-dependent suppression of TNFα production is mediated by protein kinase A-induced inhibition of Raf-1, IκB kinase β, and NFκB. J Immunol 179：4180-4186, 2007

39）Youn HS, Lim HJ, Choi YJ, et al：Selenium suppresses the activation of transcription factor NFκB and IRF3 induced by TLR3 or TLR4 agonists. Int Immunopharmacol 8：495-501, 2008

40）Singleton KD, Beckey VE, Wischmeyer PE：GLUTAMINE PREVENTS ACTIVATION OF NF-kappaB AND STRESS KINASE PATHWAYS, ATTENUATES INFLAMMATORY CYTOKINE RELEASE, AND PREVENTS ACUTE RESPIRATORY DISTRESS SYNDROME（ARDS）FOLLOWING SEPSIS. Shock 24：583-589, 2005

41）Garrett-Cox RG, Stefanutti G, Booth C, et al：Glutamine decreases inflammation in infant rat endotoxemia. J Pediatr Surg 44：523-529, 2009

42）田中芳明，小林英史，朝川貴博，他：Immunonutritionにおける各種免疫修飾成分の役割．外科治療 94：687，2006

43）田中芳明，朝川貴博：Ⅵ．日常よく遭遇する病態と栄養　周術期　1）術前栄養アセスメントと免疫栄養．合田文則（編）：よくわかる臨床栄養管理実践マニュアル，全日本病院出版会，2009，pp309-323

44）田中芳明：最新の経腸栄養剤・流動食のトレンド．PEN静脈経腸栄養ニュース 28：3-4，2010

45）Fan YY, Chapkin RS：Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 128：1411-1414, 1998

46）Johnson MM, Swan DD, Surette ME, et al：Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 127：1435-1444, 1997

. J Nutr 126：2083-2088, 1996

48）Ziboh VA, Miller CC, Cho Y：Metabolism of polyunsaturated fatty acids by skin epidermal enzymes：generation of antiinflammatory and antiproliferative metabolites. Am J Clin Nutr 71：361S-366S, 2000

49）Chapkin RS, Miller CC, Somers SD, et al：Ability of 15-hydroxyeicosatrienoic acid（15-OH-20：3）to modulate macrophage arachidonic acid metabolism. Biochem Biophys Res Commun 153：799-804, 1988

50）Ternowitz T, Fogh K, Kragballe K：15-hydroxyeicosatetranoic acid（15-HETE）specifically inhibits LTB4-induced chemotaxis of human neutrophils. Skin Pharmacol 1：93-99, 1988

neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil：possible implication in asthma. Clin Dev Immunol 11：13-21, 2004

52）McClave SA, Martindale RG, Vanek VW, et al：Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient. SCCM and ASPEN. JPEN J Parenter Enteral Nutr 33：277-316, 2009

53）Yamaguchi M, Yoshida K, Uchida M：Novel functions of bovine milk-derived alpha-lactalbumin：anti-nociceptive and anti-inflammatory activity caused by inhibiting cyclooxygenase-2 and phospholipase A2. Biol Pharm Bull 32：366-371, 2009

54）渥美義仁：目で見る臨床栄養学．臨床栄養 100：1-7，2002

55）Taniguchi N, Kaneto H, Asahi M, et al：Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes 45（Suppl 3）：S81-83, 1996

56）Sawamura T, Kume N, Aoyama T, et al：An endothelial receptor for oxidized low-density lipoprotein. Nature 386：73-77, 1997

57）井上信孝，藤田佳子，沢村達也：レクチン様酸化LDL受容体における新たな展開とその臨床的意義．日薬理誌 127：103-107，2006

58）Skripchenko ND, Sharafetdinov KhKh, Plotnikova OA, et al：Effect of selenium enriched diet on lipid peroxidation in patients with diabetes mellitus type 2. Vopr Pitan 72：14-17, 2003

59）Reddi AS, Bollineni JS：Selenium-deficient diet induces renal oxidative stress and injury via TGFβ1 in normal and diabetic rats. Kidney Int 59：1342-1353, 2001

60）Kowluru RA, Koppolu P：Diabetes-induced activation of caspase-3 in retina：effect of antioxidant therapy. Free Radic Res 36：993-993, 2002

61）Faure P：Protective effects of antioxidant micronutrients（vitamin E, zinc and selenium）in type 2 diabetes mellitus. Clin Chem Lab Med 41：995-998, 2003

62）Anderson RA, Roussel AM, Zouari N, et al：Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 20：212-218, 2001

63）Davies S, McLaren Howard J, Hunnisett A, et al：Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients--implications for the prevention of cardiovascular disease and type Ⅱ diabetes mellitus. Metabolism 46：469-473, 1997

64）Anderson RA：Chromium in the prevention and control of diabetes. Diabetes Metab 26：22-27, 2000

65）Heyland DK, Dhaliwal R, Suchner U, et al：Antioxidant nutrients：a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31：327-337, 2005